Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;22(4):323-38.
doi: 10.2165/00002512-200522040-00005.

Safety and tolerability of oral erectile dysfunction treatments in the elderly

Affiliations
Review

Safety and tolerability of oral erectile dysfunction treatments in the elderly

Andrea Salonia et al. Drugs Aging. 2005.

Abstract

Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. It is generally accepted that sexual function tends to decline with aging, which is often associated with a higher prevalence of sexual problems, including ED and loss of libido. As the mean age of men seeking medical help for sexual dysfunction continues to increase, it is important to assess the safety and tolerability of currently available medical treatments in elderly men, who often share other co-morbidities that should be carefully evaluated when any type of ED therapy is considered. With this aim in mind, a MEDLINE search was conducted from 1 January 1998 to 31 May 2004 to identify studies assessing the efficacy, safety and tolerability of treatments for ED in the elderly. Particular care was taken to assess the cardiovascular safety of oral drugs for ED in this subset of patients, who often have multiple cardiovascular risk factors which contribute to a complicated clinical scenario. The most important conclusion of the paper is that the high efficacy, reliability, safety and tolerability of oral ED treatments makes them appropriate first-line therapies for elderly patients with ED.

PubMed Disclaimer

Similar articles

References

    1. Int J Impot Res. 2001 Oct;13(5):282-90 - PubMed
    1. J Urol. 2002 Oct;168(4 Pt 1):1332-6 - PubMed
    1. Am J Cardiol. 2000 Jul 20;86(2A):41F-45F - PubMed
    1. Br J Clin Pharmacol. 2002;53 Suppl 1:45S-52S - PubMed
    1. J Am Coll Cardiol. 2002 Oct 2;40(7):1232-40 - PubMed

LinkOut - more resources